Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4162 Target Snapshot

Protein tyrosine phosphatase type IVA 3 · SINGLE PROTEIN · Homo sapiens

109Compounds
58Assays
1Approved Drugs
101.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt O75365. Use UniProt O75365 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt O75365 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Protein tyrosine phosphatase type IVA 3 as ChEMBL target CHEMBL4162, mapped to UniProt O75365. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Protein tyrosine phosphatase type IVA 3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4162
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
O75365
Protein tyrosine phosphatase type IVA 3
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Protein tyrosine phosphatase type IVA 3 is the right protein anchor across sources, using UniProt O75365 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelProtein tyrosine phosphatase type IVA 3
UniProt AccessionO75365
Component TypeProtein
Sequence Length173 aa

Protein tyrosine phosphatase type IVA 3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Protein tyrosine phosphatase type IVA 3, mapped to UniProt O75365. Sequence length is 173 aa.

Mapped IDO75365
Review nameProtein tyrosine phosphatase type IVA 3
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50101.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL4445621 7.75 IC50 18.0 Preclinical
CHEMBL4471843 7.52 IC50 30.0 Preclinical
CHEMBL4862721 6.97 IC50 107.0 Preclinical
CHEMBL3393171 6.89 IC50 128.0 Preclinical
CHEMBL4862502 6.69 IC50 206.0 Preclinical
CHEMBL55 6.52 IC50 300.0 Approved
CHEMBL2397162 6.1 IC50 800.0 Preclinical
CHEMBL207428 6.05 IC50 900.0 Preclinical
CHEMBL207958 6.05 IC50 900.0 Preclinical
CHEMBL4852178 5.94 IC50 1160.0 Preclinical
Distribution

pChEMBL Value Distribution

7
5.0
12
5.5
5
6.0
7
6.5
2
7.0
3
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PENTAMIDINE
CHEMBL55
Approved 1984
Assay Landscape

Assay Landscape

58
Total Assays
64
Tested Compounds
1
Assay Types
Binding — 58 assays, 64 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 25 3 4.5
single protein format 25 44 5.4
assay format 8 17 5.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine